HLA-DMA anticorps
Aperçu rapide pour HLA-DMA anticorps (ABIN6262285)
Antigène
Voir toutes HLA-DMA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- HLA-DMA Antibody detects endogenous levels of total HLA-DMA
-
Réactivité croisée
- Humain, Rat (Rattus)
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogène
- A synthesized peptide derived from human HLA-DMA
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:1000-3000 IHC 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C.Stable for 12 months from date of receipt
-
Date de péremption
- 12 months
-
-
- HLA-DMA (Major Histocompatibility Complex, Class II, DM alpha (HLA-DMA))
-
Autre désignation
- HLA-DMA
-
Sujet
-
Description: Plays a critical role in catalyzing the release of class II-associated invariant chain peptide (CLIP) from newly synthesized MHC class II molecules and freeing the peptide binding site for acquisition of antigenic peptides. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO.
Gene: HLA-DMA
-
Poids moléculaire
- 29 kDa
-
UniProt
- P28067
-
Pathways
- Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Antigène
-